PsygaBio

Drugs Derived from Natural Compounds

Health Tech & Life Sciences
Active
Seed Caesarea, Israel Founded 2021
Last updated 2026-06-18
Total raised
Last: 2021-09
Stage
Seed
Founded
2021
Headcount
6
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

PsygaBio is a drug discovery company focused on developing therapeutics derived from natural compounds.

Using Cannasoul's proprietary analytical platform, PsygaBio's data-driven approach, know-how, and clinical trial framework support active compound identification and development, from mushroom cultivation and extraction to clinically approved formulations.

PsygaBio, in partnership with Cannasoul Analytics, aims to exploit the diversity found in the psychedelic mushroom realm to identify active compounds and formulations for therapeutic benefits.

PsygaBio is a subsidiary of Cannasoul Analytics.

Funding history · 1 round · — total

2021-09
Undisclosed

Q&A

What is PsygaBio's primary focus?
PsygaBio is a drug discovery company focused on developing therapeutics derived from natural compounds.
When was PsygaBio founded?
PsygaBio was founded in April 2021.
Who is the Co-founder and CEO of PsygaBio?
Shmuel Mandel is the Co-founder and CEO of PsygaBio.
What is PsygaBio's current stage of funding?
PsygaBio is currently in the Seed stage.
Which investor participated in PsygaBio's funding round in September 2021?
NFX Capital participated in PsygaBio's funding round in September 2021.
What is PsygaBio's relationship with Cannasoul Analytics?
PsygaBio is a subsidiary of Cannasoul Analytics and partners with them to identify active compounds and formulations from psychedelic mushrooms.
Where is PsygaBio headquartered?
PsygaBio is headquartered in Caesarea, Israel.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsCellsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Tags

geneticspharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)